COVID-19 Outpatients: Early Risk-Stratified Treatment with Zinc Plus Low-Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study

Peer reviewed research by Roland Derwand, Martin Scholz, and Vladimir Zelenko shows that zinc, HCQ and azithromycin significantly reduce COVID hospitalization and mortality.

COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study – ScienceDirect

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: